Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALBATROSS: Spironolactone in Acute Myocardial Infarction
NCT01059136Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2010
- Primary completion
- Aug 2014
- Countries
- 1
01
Overview
A Phase 3 trial of spironolactone in myocardial infarction (MI), sponsored by Assistance publique - Hôpitaux de Paris. Started Feb 2010; status: completed.
02
Drugs
spironolactone
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01059136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059136.